Cargando…

Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine

Investigation of the precise mechanisms of attention deficit and hyperactivity disorder (ADHD) and other dopamine-associated conditions is crucial for the development of new treatment approaches. In this study, we assessed the effects of repeated and acute administration of α2A-adrenoceptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volnova, Anna, Kurzina, Natalia, Belskaya, Anastasia, Gromova, Arina, Pelevin, Arseniy, Ptukha, Maria, Fesenko, Zoia, Ignashchenkova, Alla, Gainetdinov, Raul R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856099/ https://www.ncbi.nlm.nih.gov/pubmed/36672730 http://dx.doi.org/10.3390/biomedicines11010222

Ejemplares similares

Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats
por: Ptukha, Maria, et al.
Publicado: (2022)

Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats via α2A-Adrenoceptors
por: Kurzina, Natalia, et al.
Publicado: (2022)

A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition
por: Kurzina, Natalia P., et al.
Publicado: (2021)

A Custom Solution for Acoustic Startle Response Setup with Spike2-Based Data Acquisition Interface
por: Pelevin, Arseniy, et al.
Publicado: (2023)

Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
por: Savchenko, Artem, et al.
Publicado: (2023)

Evaluation of Approach to a Conspecific and Blood Biochemical Parameters in TAAR1 Knockout Mice
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson’s Disease Therapy
por: Sukhanov, Ilya, et al.
Publicado: (2022)

Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure
por: Vilca, Samara, et al.
Publicado: (2023)

Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females
por: Pardo, Marta, et al.
Publicado: (2022)

In Vitro and In Vivo Study of the Short-Term Vasomotor Response during Epileptic Seizures
por: Volnova, Anna, et al.
Publicado: (2020)

A computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque
por: Hassani, S. A., et al.
Publicado: (2017)

Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice
por: Cubells, Joseph F., et al.
Publicado: (2016)

Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis
por: Efimova, Evgeniya V., et al.
Publicado: (2022)

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer’s Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments
por: Hoang, Karen, et al.
Publicado: (2022)

The Anti-Epileptic Effects of Carbenoxolone In Vitro and In Vivo
por: Volnova, Anna, et al.
Publicado: (2022)

Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia
por: Cinque, Stefano, et al.
Publicado: (2018)

Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays
por: Cichero, Elena, et al.
Publicado: (2023)

Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex
por: Devoto, Paola, et al.
Publicado: (2020)

Arc protein, a remnant of ancient retrovirus, forms virus-like particles, which are abundantly generated by neurons during epileptic seizures, and affects epileptic susceptibility in rodent models
por: Sibarov, Dmitry A., et al.
Publicado: (2023)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Metabolite profiling of guanfacine in plasma and urine of healthy Japanese subjects after oral administration of guanfacine extended‐release tablets
por: Inoue, Yuji, et al.
Publicado: (2019)

Attention deficits following ADEM ameliorated by guanfacine
por: Singh-Curry, Victoria, et al.
Publicado: (2010)

Effect of Enteral Guanfacine on Dexmedetomidine Use in the ICU
por: Fetters, Megan B., et al.
Publicado: (2022)

Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study
por: Sanna, Fabrizio, et al.
Publicado: (2020)

Selective inhibition of dopamine‐beta‐hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex
por: Devoto, Paola, et al.
Publicado: (2015)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008)

An in vitro evaluation of guanfacine as a substrate for P-glycoprotein
por: Gillis, Nancy K, et al.
Publicado: (2011)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

T47. GUANFACINE AUGMENTATION OF ATTENTIONAL FUNCTIONING IN THE SCHIZOPHRENIA SPECTRUM
Publicado: (2020)

A Retrospective Analysis of Guanfacine for the Pharmacological Management of Delirium
por: Jiang, Shixie, et al.
Publicado: (2023)

Novel translational rat models of dopamine transporter deficiency
por: Leo, Damiana, et al.
Publicado: (2018)

Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis
por: Ermine, Charlotte M., et al.
Publicado: (2018)

Guanfacine for the Treatment of Cognitive Disorders: A Century of Discoveries at Yale
por: Arnsten, Amy F.T., et al.
Publicado: (2012)

Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)

Stressing the potential of guanfacine as a treatment for cocaine use disorder
por: Lustberg, Daniel, et al.
Publicado: (2020)

Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
por: Fukuyama, Kouji, et al.
Publicado: (2021)

Guanfacine as an effective drug for the treatment of tic disorder. Case report
por: Del Sol Calderon, P., et al.
Publicado: (2021)

Role of the trace amine associated receptor 5 (TAAR5) in the sensorimotor functions
por: Kalinina, D. S., et al.
Publicado: (2021)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Combined α(2)- and D(2)-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals
por: Sagheddu, Claudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ibn8vv4l1ovqi6p4i7l6b0kanq